J Liver Cancer Search

CLOSE


Current issue

  • HOME
  • BROWSE ARTICLES
  • Current issue
Volume 22(2); Sep 2022
Editorial
Is direct-acting antiviral treatment beneficial or harmful for patients with hepatitis C virus-related hepatocellular carcinoma?
Hye Won Lee
J Liver Cancer. 2022;22(2):91-92.   Published online September 29, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Review Articles
Combination of interventional oncology local therapies and immunotherapy for the treatment of hepatocellular carcinoma
Dong-Hyun Kim
J Liver Cancer. 2022;22(2):93-102.   Published online April 22, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma
Eun-Ji Choi, Young-Joon Kim
J Liver Cancer. 2022;22(2):103-114.   Published online September 22, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Original Articles
The dual role of transforming growth factor-beta signatures in human B viral multistep hepatocarcinogenesis: early and late responsive genes
Jeong Eun Yoo, Ji Hae Nahm, Young-Joo Kim, Youngsic Jeon, Young Nyun Park
J Liver Cancer. 2022;22(2):115-124.   Published online May 20, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment
Young-Hwan Ahn, Heirim Lee, Ji Eun Han, Hyo Jung Cho, Jae Youn Cheong, Bumhee Park, Soon Sun Kim
J Liver Cancer. 2022;22(2):125-135.   Published online June 28, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study
Jeong Yun Jang, Jinhong Jung, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jin-hong Park, Sang Min Yoon
J Liver Cancer. 2022;22(2):136-145.   Published online September 16, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Indications for open hepatectomy in the era of laparoscopic liver resection: a high volume single institutional study
Sung Jun Jo, Jinsoo Rhu, Jong Man Kim, Gyu-Seong Choi, Jae-Won Joh
J Liver Cancer. 2022;22(2):146-157.   Published online September 14, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Clinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiology
Wonjoon Jang, Hye Won Lee, Jae Seung Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Do Young Kim
J Liver Cancer. 2022;22(2):158-166.   Published online September 27, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
The diagnostic value of circulating tumor DNA in hepatitis B virus induced hepatocellular carcinoma: a systematic review and meta-analysis
Young Chang, Soung Won Jeong, Jae Young Jang, Hyuksoo Eun, Young‑Sun Lee, Do Seon Song, Su Jong Yu, Sae Hwan Lee, Won Kim, Hyun Woong Lee, Sang Gyune Kim, Seongho Ryu, Suyeon Park
J Liver Cancer. 2022;22(2):167-177.   Published online September 29, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Case Reports
Fibrolamellar hepatocellular carcinoma that was successfully treated with surgical resection: a case report
Seong Kyun Na
J Liver Cancer. 2022;22(2):178-182.   Published online June 22, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Novel management of expected post-radiotherapy complications in hepatocellular carcinoma patients: a case report
Sung Hoon Chang, Tae Suk Kim, Yong Hwan Jeon, Nuri Hyun Jung, Dae Hee Choi
J Liver Cancer. 2022;22(2):183-187.   Published online August 24, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Hepatocellular carcinoma diagnosed in a patient who had Fontan operation 30 years ago: a case report
Moon Haeng Hur, Haeryoung Kim, Jeong-Hoon Lee
J Liver Cancer. 2022;22(2):188-193.   Published online August 31, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Hepatocellular carcinoma with Budd-Chiari syndrome due to membranous obstruction of the inferior vena cava with long-term follow-up: a case report
Choong Hee Kim, Gwang Hyeon Choi, Hee Young Na, Chang Jin Yoon, Jai Young Cho, Sangmi Jang, Ji Hye Kim, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong
J Liver Cancer. 2022;22(2):194-201.   Published online September 15, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Multidisciplinary approach for hepatocellular carcinoma arising from cirrhotic liver with Budd-Chiari syndrome: a case report
Sangmi Kim, Ji Hoon Kim, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung
J Liver Cancer. 2022;22(2):202-206.   Published online September 20, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Notice of Retraction and Replacement
Yoon et al. Hepatocellular Carcinoma in Korea: an Analysis of the 2015 Korean Nationwide Cancer Registry
Jeong-Hoon Lee
J Liver Cancer. 2022;22(2):207-207.   Published online June 8, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
  • KoreaMed
  • KoMCI
  • GoogleScholar
  • DOAJ
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR AUTHORS AND REVIEWERS
Editorial Office
620 Yeoksam Heights Bldg.(FASTFIVE),151 Teheran-ro, Gangnam-gu, Seoul 06132, Korea
Tel: +82-2-313-1900    E-mail: liver@klcsg.or.kr                

Copyright © 2022 by The Korean Liver Cancer Association.

Developed in M2PI

Close layer
prev next